Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1999-1-12
|
pubmed:abstractText |
A number of sulfonic acid ester derivatives of serotonin (5-hydroxytryptamine; 5-HT; 1) were prepared and their affinities are compared to that of the reference compound 5-[[(trifluoromethyl)sulfonyl]oxy]-tryptamine (8b). The structure-affinity relationship (SAFIR) is discussed in terms of in vitro binding for cloned human h5-HT1A, h5-HT1B and h5-HT1D receptors. All tryptamine derivatives exhibited the best affinities for h5-HT1D receptors but still, these were comparatively lower than that of compound 8b. 5-Tosylated tryptamine 11b (Ki = 6 nM) and the sulfamate derivatives 13b and 14b (Ki = 7 and 11 nM, respectively) were found to have the highest affinities for the h5-HT1D receptor. Other tryptamine derivatives displayed moderate binding for h5-HT1A and h5-HT1B receptors, along with Ki values ranging from 14-20 nM for the h5-HT1D sites. In addition, the syntheses of two alkylamino side chain restricted derivatives are described. 3-Amino-6-[[(trifluoromethyl)sulfonyl]oxy]-1,2,3,4-tetrahydrocarbazol e 21, as well as 4-[5-[[(trifluoromethyl)sulfonyl]oxy]-1H-indol-3-yl]piperidines 24 and 25, induced a shift in selectivity in favor of the h5-HT1B receptor. The relatively longer distance between the basic amine and a hydrogen-bond accepting oxygen in 21, 24 and 25 as compared to the non-restricted tryptamines, is likely responsible for this observation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/HTR1B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT1B,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT1D,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tryptamines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0968-0896
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1469-79
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9801818-Animals,
pubmed-meshheading:9801818-COS Cells,
pubmed-meshheading:9801818-Crystallography, X-Ray,
pubmed-meshheading:9801818-HeLa Cells,
pubmed-meshheading:9801818-Humans,
pubmed-meshheading:9801818-Magnetic Resonance Spectroscopy,
pubmed-meshheading:9801818-Mass Spectrometry,
pubmed-meshheading:9801818-Protein Binding,
pubmed-meshheading:9801818-Receptor, Serotonin, 5-HT1B,
pubmed-meshheading:9801818-Receptor, Serotonin, 5-HT1D,
pubmed-meshheading:9801818-Receptors, Serotonin,
pubmed-meshheading:9801818-Recombinant Proteins,
pubmed-meshheading:9801818-Structure-Activity Relationship,
pubmed-meshheading:9801818-Tryptamines
|
pubmed:year |
1998
|
pubmed:articleTitle |
5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structure-affinity relationships for h5-HT1B and h5-HT1D receptors.
|
pubmed:affiliation |
Department of Medicinal Chemistry, University of Groningen, The Netherlands. tjeerd.barf@eu.pnu.com
|
pubmed:publicationType |
Journal Article
|